Author:
Montastruc François, ,Gardette Virginie,Cantet Christelle,Piau Antoine,Lapeyre-Mestre Maryse,Vellas Bruno,Montastruc Jean-Louis,Andrieu Sandrine
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference44 articles.
1. Viktil KK, Blix HS, Moger TA, Reikvam A (2007) Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 63:187–195
2. Agence de Sécurité Sanitaire des Produits de Santé (Afssaps) and Réseau Français des Centres Régionaux de Pharmacovigilance (AFCRPV) Etude PEIMA (2011) Prévalence des effets indésirables médicamenteux chez les patients atteints de la maladie d’Alzheimer ou d’un syndrome démentiels. Available at: http://www.chu-montpellier.fr/publication/inter_pub/R361/A7610/RapportPEIMAfinal.pdf
3. Onder G, Gambassi G, Scales CJ, Cesari M, Vedova CD, Landi F, Bernabei R (2002) Adverse drug reactions and cognitive function among hospitalized older adults. Eur J Clin Pharmacol 58:371–377
4. Ganjavi H, Herrmann N, Rochon PA, Sharma P, Lee M, Cassel D et al (2007) Adverse drug events in cognitively impaired elderly patients. Dement Geriatr Cogn Disord 23:395–400
5. Chang CB, Chen JH, Wen CJ, Kuo HK, Lu IS, Chiu LS, Wu SC, Chan DC (2011) Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria. Br J Clin Pharmacol 72:482–489
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献